Drug insurance: a single payer pharmacare program would jeopardise coverage quality for 21 million Canadians

22 February 2024 - Imposing a single payer universal drug insurance plan on all Canadians would jeopardise coverage quality for ...

Read more →

Data sharing a a new era for research funded by the US Government

15 November 2023 - In January 2023, the NIH implemented its new Data Management and Sharing Policy.  ...

Read more →

Launch of the Australian Cancer Plan

2 November 2023 - Learn about the new Australian Cancer Plan, which aims to improve prevention, screening, treatment and management of ...

Read more →

We need a public option for pharmaceuticals

20 October 2023 - America is currently facing dual public health crises of record drug shortages and skyrocketing prices.  ...

Read more →

Act’s productivity perspective on PHARMAC medication and treatments will hurt minorities

11 September 2023 - Act is proposing a “productivity perspective based on real lives” when it comes to delivering PHARMAC ...

Read more →

How a controversial US drug policy could be harming cancer patients worldwide

9 August 2023 - The FDA’s accelerated approval process was designed to help people access life saving drugs.  ...

Read more →

How industrial policy could accelerate innovation in the life sciences

8 August 2023 - The US is expanding public investment in the technology-based industries, including the life sciences, in a move ...

Read more →

Novel Alzheimer disease treatments and reconsideration of US pharmaceutical reimbursement policy

17 July 2023 - While donanemab appears to be among the first therapies to demonstrate measurable clinical benefit for Alzheimer's disease, ...

Read more →

A priority review voucher program to fuel generic drug development

6 July 2023 - Millions of Americans report that they are unable to fill their prescriptions or are not taking their ...

Read more →

Korea’s drug pricing policies for the second half of 2023

22 June 2023 - In the first half of 2023, the Ministry of Health and Welfare set up a public ...

Read more →

A review of labeling based on patient reported outcome endpoints for new oncology drugs approved by the EMA (2017-2021)

9 June 2023 - A review of new oncology indications approved by the EMA for 2012-2016 showed that 33% of new ...

Read more →

ASCO policy statement on biosimilar and interchangeable products in oncology

12 April 2023 - Given the current market dynamics and the regulatory landscape, this ASCO manuscript now seeks to propose several ...

Read more →

State of the Union highlights America’s awkward conversation on financing the development of new medicines

9 February 2023 - Science, medicine, health care, and paying for medicines featured prominently in President Joe Biden’s State of ...

Read more →

Medical technology strategy

3 February 2023 - This document presents the inaugural UK medtech strategy and the timing could not be better.  ...

Read more →

Private insurance can contribute to a healthier system

24 January 2023 - Given what many describe as a crisis in primary care, it’s well past time to revisit the ...

Read more →